LYRA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.372 USD | +2.59% |
|
-11.43% | -92.90% |
| 07/05 | Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50 | MT |
| 07/05 | HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LYRA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +2.59% | -11.43% | -92.90% | -85.75% | - | 22.11M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LYRA Stock
- Charts Lyra Therapeutics, Inc.
- Comparison Chart